Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)

Gastrointestinal Endoscopy

Volumn 71, Issue 7, 2010, Pages 1114-1121

  Jost, Christian ^a   Binek, Janek ^a   Schuller, Jan C ^a   Bauerfeind, Peter ^a   Metzger, Urs ^a   Werth, Baseli ^a   Knuchel, Juerg ^a   Frossard, Jean Louis ^a   Bertschinger, Philipp ^a   Brauchli, Peter ^a   Meyenberger, Christa ^a   Ruhstaller, Thomas ^a  

^a Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; ANTINEOPLASTIC AGENT; RADIOSENSITIZING AGENT; TAXOID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SWITZERLAND; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT THERAPY; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; DISEASE COURSE; DRUG COMBINATION; ECHOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME;

EID: 77952958246     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2009.12.015     Document Type: Article

References (26)

1. Lightdale C.J., and Kulkarni K.G. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 23 (2005) 4483-4489
2. Chak A., Canto M.I., Cooper G.S., et al. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 88 (2000) 1788-1795
3. Willis J., Cooper G.S., Isenberg G., et al. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc 55 (2002) 655-661
4. Shinkai M., Niwa Y., Arisawa T., Ohmiya N., Goto H., and Hayakawa T. Evaluation of prognosis of squamous cell carcinoma of the oesophagus by endoscopic ultrasonography. Gut 47 (2000) 120-125
5. Isenberg G., Chak A., Canto M., et al. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation. Gastrointest Endosc 48 (1998) 158-163
6. Hirata N., Kawamoto K., Ueyama T., Masuda K., Utsunomiya T., and Kuwano H. Using endosonography to assess the effects of neoadjuvant therapy in patients with advanced esophageal cancer. AJR Am J Roentgenol 169 (1997) 485-491
7. Faigel D. EUS in patients with benign and malignant lymphadenopathy. Gastrointest Endosc 53 (2001) 593-598
8. Eloubeidi M.A., Wallace M.B., Reed C.E., et al. The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience. Gastrointest Endosc 54 (2001) 714-719
9. Catalano M.F., Fazel A., Nawras A.T., and Geenen J.E. Diagnosis of lymph node metastasis by endoscopic ultrasound (EUS): comparison of endosonographic features with results of EUS-guided fine needle aspiration (FNA) [abstract]. Gastrointest Endosc 55 (2002) AB236
10. Ruhstaller T., Widmer L., Schuller J.C., et al. Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol 20 (2009) 1522-1528
11. Wallace M.B., Hawes R.H., Sahai A.V., Van Velse A., and Hoffman B.J. Dilation of malignant esophageal stenosis to allow EUS guided fine- needle aspiration: safety and effect on patient management. Gastrointest Endosc 51 (2000) 309-313
12. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
13. Schneider P.M., Baldus S.E., Metzger R., et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. implications for response classification. Ann Surg 242 (2005) 684-692
14. Brucher B.L., Becker K., Lordick F., et al. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 106 (2006) 2119-2127
15. Van Dam J. Endosonographic evaluation of the patient with esophageal cancer. Chest 112 4 Suppl (1997) 184S-190S
16. Cerfolio R.J., Bryant A.S., Ohja B., Bartolucci A.A., and Eloubeidi M.A. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 129 (2005) 1232-1241
17. Kelsen D.P., Winter K.A., Gunderson L.L., et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25 (2007) 3719-3725
18. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
19. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
20. Ancona E., Ruol A., Santi S., et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 91 (2001) 2165-2174
21. Bowrey D.J., Clark G.W., Roberts S.A., et al. Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus. J Gastrointest Surg 3 (1999) 462-467
22. Beseth B.D., Bedford R., Isacoff W.H., Holmes E.C., and Cameron R.B. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 66 (2000) 827-831
23. Sulfaro S., Frustaci S., Volpe R., Barzan L., Comoretto R., Monfardini S., et al. A pathologic assessment of tumor residue and stromal changes after intraarterial chemotherapy for head and neck carcinomas. A study on serial sections of the whole surgical specimen. Cancer 64 (1989) 994-1001
24. Prenzel K.L., Konig A., Schneider P.M., et al. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer. Ann Surg Oncol 14 (2007) 954-959
25. Chirieac L.R., Swisher S.G., Ajani J.A., Komaki R.R., Correa A.M., Morris J.S., et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103 (2005) 1347-1355
26. Mesenas S., Vu C., McStay M., et al. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy. Dis Esophagus 21 (2008) 37-42